fluorocholine (18f) synektik süstelahus
synektik s.a. - fluorokoliin (18f) - süstelahus - 1gbq 1ml 25ml 1tk; 1gbq 1ml 15ml 1tk
f-18-fluorocholine süstelahus
map medical technologies oy - fluorokoliin (18f) - süstelahus - 2tk
iasocholine 1 gbq/ml, süstelahus süstelahus
iason gmbh - fluorokoliin (18f) - süstelahus - 1gbq 1ml 15ml 1tk
(18f) fch süstelahus
map medical technologies oy - fluorokoliin (18f) - süstelahus - 1tk
doloproct 1mg/20mg/g rektaalkreem rektaalkreem
karo pharma ab - fluokortoloon+lidokaiin - rektaalkreem - 1mg+20mg 1g 10g 1tk; 1mg+20mg 1g 15g 1tk; 1mg+20mg 1g 30g 1tk
pylclari
curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
doloproct 1mg/40mg rektaalsuposiidid rektaalsuposiit
karo pharma ab - fluokortoloon+lidokaiin - rektaalsuposiit - 1mg+40mg 10tk; 1mg+40mg 3tk; 1mg+40mg 120tk